by: Newsday
by: techxplore
by: MSN
by: MSN
ChatGPT, supercomputers & robots, explained in Malayalam. Kerala govt launches AI encyclopaedia
by: timesnownews
Nothing Phone 3 Launch Date, Price In India, Design, Specs, Latest Leaks, What To Expect This Year
by: techxplore
by: LancasterOnline
Lampeter-Strasburg administrator outlines plan to implement new state science standards
by: timesnownews
Valorant Patch 10.00: Major Updates, New Agent Tejo, Map Changes, How To Download And More
by: MSN
by: MSN
A milestone in biotechnology research: PM Modi unveils genome sequencing data of 10,000 Indians
by: MSN
Vir jumps after Phase 1 data for Sanofi-partnered cancer drug technology
Shares of Vir Biotechnology (CIR) climbed ~42% in the premarket on Wednesday after the company posted initial Phase 1 data for two antitumor agents developed using its PRO-XTEN masking technology, in-licensed from Sanofi (NASDAQ:SNY).

Read the Full MSN Article at:
https://www.msn.com/en-us/science/biochemistry/vir-jumps-after-phase-1-data-for-sanofi-partnered-cancer-drug-technology/ar-AA1xaULT
on: Mon, Dec 02nd 2024
by: Tim Hastings
Indian-origin CEO strikes 'significant' UK deal to combat cancer, dementia